Over the past 12 months, 8 insiders at Revolution Medicines, Inc. filed 72 open-market SEC Form 4 transactions on RVMD: 0 purchases worth $0 and 72 sales worth $67.8M. Insiders have been net sellers over this period. The most recent filing was on Jun 24, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 24, 26 | Jack AndersChief Financial Officer | SELL | 9.5K | $170.32 | $1.6M |
| Jun 16, 26 | Jack AndersChief Financial Officer | SELL | 2.7K | $156.12 | $425K |
| Jun 16, 26 | Jeff CisliniGeneral Counsel | SELL | 2.2K | $156.12 | $337K |
| Jun 16, 26 | Mark A GoldsmithSee Remarks | SELL | 10.0K | $156.12 | $1.6M |
| Jun 16, 26 | Stephen Michael KelseySee Remarks | SELL | 4.2K | $156.12 | $652K |
| May 26, 26 | Anthony ManciniSee Remarks | SELL | 2.0K | $154.82 | $308K |
| Apr 15, 26 | Mark A GoldsmithSee Remarks | SELL | 120.0K | $150.09 | $18.0M |
| Mar 25, 26 | Anthony ManciniSee Remarks | SELL | 21.1K | $97.21 | $2.0M |
| Mar 19, 26 | Jeff CisliniGeneral Counsel | SELL | 1.2K | $97.44 | $113K |
| Mar 17, 26 | Jack AndersChief Financial Officer | SELL | 2.8K | $99.48 | $274K |
| Mar 17, 26 | Jeff CisliniGeneral Counsel | SELL | 1.8K | $99.48 | $179K |
| Mar 17, 26 | Mark A GoldsmithSee Remarks | SELL | 12.9K | $99.48 | $1.3M |
| Mar 17, 26 | Margaret A HornChief Operating Officer | SELL | 4.6K | $99.48 | $456K |
| Mar 17, 26 | Stephen Michael KelseySee Remarks | SELL | 4.3K | $99.48 | $428K |
| Mar 17, 26 | Xiaolin WangSee Remarks | SELL | 2.0K | $99.48 | $200K |
| Mar 17, 26 | Lin WeiChief Medical Officer | SELL | 2.1K | $99.48 | $206K |
| Mar 2, 26 | Mark A GoldsmithSee Remarks | SELL | 21.3K | $102.20 | $2.2M |
| Jan 21, 26 | Jeff CisliniGeneral Counsel | SELL | 908 | $115.60 | $105K |
| Jan 7, 26 | Jack AndersChief Financial Officer | SELL | 10.0K | $98.00 | $980K |
| Jan 7, 26 | Margaret A HornChief Operating Officer | SELL | 53.1K | $102.90 | $5.3M |
| Dec 16, 25 | Jack AndersChief Financial Officer | SELL | 3.1K | $77.09 | $239K |
| Dec 16, 25 | Jeff CisliniGeneral Counsel | SELL | 2.7K | $76.82 | $206K |
| Dec 16, 25 | Mark A GoldsmithSee Remarks | SELL | 15.4K | $76.82 | $1.2M |
| Dec 16, 25 | Margaret A HornChief Operating Officer | SELL | 4.8K | $76.82 | $372K |
| Dec 16, 25 | Stephen Michael KelseySee Remarks | SELL | 5.4K | $76.82 | $418K |
| Nov 25, 25 | Jack AndersChief Financial Officer | SELL | 5.4K | $74.00 | $401K |
| Nov 25, 25 | Mark A GoldsmithSee Remarks | SELL | 60.0K | $75.08 | $4.5M |
| Nov 18, 25 | Jeff CisliniGeneral Counsel | SELL | 13.4K | $70.14 | $939K |
| Nov 18, 25 | Mark A GoldsmithSee Remarks | SELL | 20.0K | $70.38 | $1.4M |
| Nov 12, 25 | Mark A GoldsmithSee Remarks | SELL | 20.0K | $65.07 | $1.3M |
| Nov 11, 25 | Jack AndersChief Financial Officer | SELL | 10.0K | $64.00 | $640K |
| Nov 7, 25 | Mark A GoldsmithSee Remarks | SELL | 30.0K | $60.31 | $1.8M |
| Oct 17, 25 | Jeff CisliniGeneral Counsel | SELL | 12.0K | $55.00 | $660K |
| Oct 17, 25 | Mark A GoldsmithSee Remarks | SELL | 10.0K | $55.00 | $550K |
| Oct 16, 25 | Mark A GoldsmithSee Remarks | SELL | 10.0K | $50.47 | $505K |
| Oct 13, 25 | Stephen Michael KelseySee Remarks | SELL | 25.0K | $48.54 | $1.2M |
| Sep 24, 25 | Jeff CisliniGeneral Counsel | SELL | 1.8K | $44.26 | $80K |
| Sep 16, 25 | Jack AndersChief Financial Officer | SELL | 2.3K | $45.82 | $106K |
| Sep 16, 25 | Jeff CisliniGeneral Counsel | SELL | 1.9K | $45.82 | $86K |
| Sep 16, 25 | Mark A GoldsmithSee Remarks | SELL | 13.4K | $45.82 | $614K |
| Sep 16, 25 | Margaret A HornChief Operating Officer | SELL | 4.8K | $45.82 | $219K |
| Sep 16, 25 | Stephen Michael KelseySee Remarks | SELL | 5.4K | $45.82 | $246K |
| Sep 16, 25 | Lin WeiChief Medical Officer | SELL | 2.2K | $45.82 | $99K |
| Sep 15, 25 | Stephen Michael KelseySee Remarks | SELL | 23.7K | $46.93 | $1.1M |
| Sep 11, 25 | Stephen Michael KelseySee Remarks | SELL | 55.9K | $44.48 | $2.5M |
| Sep 3, 25 | Jack AndersChief Financial Officer | SELL | 5.2K | $40.17 | $210K |
| Sep 2, 25 | Jack AndersChief Financial Officer | SELL | 4.8K | $40.02 | $191K |
| Jun 20, 25 | Jeff CisliniGeneral Counsel | SELL | 1.9K | $39.61 | $76K |
| Jun 16, 25 | Jack AndersChief Financial Officer | SELL | 2.2K | $39.83 | $86K |
| Jun 16, 25 | Jeff CisliniGeneral Counsel | SELL | 1.9K | $39.83 | $75K |
Over the past 12 months, insiders at Revolution Medicines, Inc. filed 0 open-market purchases worth $0 and 72 sales worth $67.8M on RVMD, which makes them net sellers over the period. The most recent Form 4 was filed on Jun 24, 26.
8 different insiders at Revolution Medicines, Inc. filed open-market SEC Form 4 transactions on RVMD over the last 12 months.
InsiderTape plots every RVMD insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Revolution Medicines, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →